June 24–26, 2027, Rome, Italy

Scientific Program · Heart Congress 2025

Heart Congress 2025 — Scientific Program

Day-by-day session and presentation schedule

The full Heart Congress 2025 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Keynote

    The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF

    Thomas Bernd Dschietzig · Relaxera GmbH & Co. KG, Germany

    Human relaxin-2 (hRlx-2) is a hormone of pregnancy that has engendered a great deal of interest as a therapy for various cardiovascular and inflammatory diseases, among them Acute Heart Failure and Systemic Scleroderma.…

  2. Keynote

    Innovative mechanisms, consequences and therapeutics for pulmonary hypertension

    Yong Xiao Wang · Albany Medical College, United States

    Currently, pulmonary hypertension (PH) is a widespread lung disease, molecular mechanisms remain poorly understanded, and medications are neither always effective nor specific. In a series of our present studies, we…

  3. Keynote

    Personalized and Precision Medicine (PPM) as a unique healthcare model through bio design-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety

    Sergey Suchkov · N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

    A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM) . To achieve the implementation of PPM concept, it is necessary…

  4. Keynote

    Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension

    Miroslav Radenkovic · University of Belgrade, Serbia

    Pulmonary arterial hypertension (PAH) remains a debilitating disease with high morbidity and mortality. It is a rare, progressive and ultimately life-threatening disease in which blood vessels in the lungs thicken and…

  5. Keynote · Virtual

    Association between endothelial dysfunction assessed by Reactive Hyperemia Index (LnRHI) and diabetes mellitus in heart transplant recipients

    Armele Dornelas de Andrade · Federal University of Pernambuco, Brazil

    Background: Endothelial dysfunction (ED) is a key factor in cardiovascular disease and is commonly observed in heart transplant (HTx) recipients. The reactive hyperemia index (LnRHI) is a validated, noninvasive marker…

  6. Keynote · Virtual

    Determinants of arterial compliance and vascular resistance in healthy children and adolescents

    Maria da Gloria Rodrigues Machado · Faculty of Medical Sciences of Minas Gerais, Brazil

    Backgroud: Early exposure to cardiovascular risk factors during childhood is associated with impaired arterial distensibility, as well as other vascular alterations, suggesting that biomarkers of vascular aging can be…

  7. Keynote · Virtual

    The management of hypercholesteremia with lipid lowering therapy inclisiran

    Kalpesh Patel · Barts Health NHS Trust, United Kingdom

    Increasing prevalence of cardiovascular disease leading to events such as myocardial infarction requires aggressive management of secondary prevention therapy. Lipid lowering treatments which target low density…

  8. Keynote · Virtual

    Association of arterial stiffness and changes in intrinsic capacity through the locomotion domain in elderly people in primary care

    Maria da Gloria Rodrigues Machado · Faculty of Medical Sciences of Minas Gerais, Brazil

    Aging is one of the risk factors for cardiovascular diseases. In particular, excessive pulsatility is associated with microvascular lesions in high-flow organs, such as the brain and kidney, suggesting that small…

  9. Keynote · Virtual

    Periodontal and cardiovascular disease: Shared pathophysiology and therapeutic implications – New insights for 2025

    Neda Najafimakhsoos · University of Bologna, Italy

    Periodontal disease is increasingly recognized as a significant systemic contributor to atherosclerosis. Key oral pathogens—Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Treponema denticola, and…

  10. Oral

    A decade of DCD heart transplantation utilising normothermic machine perfusion in Australia

    Claudio Soto · St Vincent's Hospital, Australia

    The use of donation after circulatory death (DCD) donors for heart transplantation represents a relatively new entry into efforts made to help expand the donor pool. The use of Normothermic Machine Perfusion (NMP)…

  11. Oral

    Mechanical valve for isolated mitral stenoses complicated massive thromboses of left atrium: Is it necessary?

    Valery Boukarim · Amosov National Institute of Cardiovascular Surgery, Ukraine

    Objective: To analyzed main problems in surgery of mitral valve diseases (MVD) complicated by left atrium`s massive thromboses (LAMT) (thromboses more than 1/3 of left atrium`s volume). Materials and Methods: 336 adult…

  12. Oral

    Paravetebral block with liposomal bupivacaine for enhanced recovery in open thoracotomy: A case report

    Vivek Vaibhav · Saraswathi Institute of Medical Sciences, India

    A 77-year-old Female patient underwent an open thoracotomy for lung B/L breast cancer. Preoperative PVB was performed at the T5-T7 levels, using a combination of liposomal bupivacaine and standard bupivacaine for both…

  13. Oral

    Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages

    Sergey Suchkov · N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

    Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs…

  14. Oral

    Cardiac surgery in patients with low ejection fraction

    Nuruddin Mohammod Zahangir · Green Life Medical College Hospital, Bangladesh

    Objective: To see the outcome of cardiac surgery in patients with low ejection fraction. Methods: We retrospectively reviewed 2382 cardiac surgery cases from 11.6.17 to 24.3.25. Among them CABG was performed in 2278…

  15. Oral

    A rare case of slow flow mimicking acute coronary syndrome

    Nidhish Niranjan Nisty · Nisty Heart Centre, India

    Introduction: The coronary slow flow phenomenon is an important, angiographic entity characterized by delayed progression of the injected contrast medium through the coronary tree. The clinical implications are…

  16. Oral

    Automated assessment of atrial septal defects using deep learning

    Zhang Xin · Capital Medical University, China

    Aim: Atrial septal defect (ASD) is a typical cardiac defect in the atrial septum, which accounts for around 10% of congenital heart disease (CHD). The early diagnosis and treatment of ASD are crucial to avoid serious…

  17. Oral

    Double-chambered left ventricle - From clinical to basic

    Fangyun Wang · Capital Medical University, China

    Introduction: Double-chambered left ventricle (DCLV) is a particularly rare congenital cardiovascular malformation that is difficult to diagnose. It is characterized by the subdivision of the left ventricle into two…

  18. Oral

    Diagnosis and prognosis of abnromal origin of coronary arteries

    Ma Ning · Capital Medical University, China

    Objective: To investigate the diagnostic and prognostic value of echocardiography in patients with anomalous origin of the coronary arteries(AOCA),and to analyze its diagnostic accuracy and impact on patient outcomes.…

Day 2

Day 2

  1. Keynote · In-Person

    Comparison of minimally invasive and conventional coronary artery bypass grafting in patients older than 75 years

    Bufan Zhang · Tianjin Medical University General Hospital, China

    Objective: Coronary artery bypass grafting (CABG) via sternotomy is the standard and conventional procedure for patients with multivessel coronary artery disease. Minimally invasive coronary artery bypass grafting (MICS…

  2. Keynote · In-Person

    Constrictive pericarditis following lung transplantation: A rare cardiovascular complication in idiopathic pulmonary fibrosis

    Abdul Rahman Elhassan · National University - Sudan, Saudi Arabia

    Constrictive pericarditis is an uncommon but serious complication of lung transplantation, marked by pericardial fibrosis and impaired diastolic filling. It can lead to significant morbidity if not recognized and…

  3. Keynote · In-Person

    Association of red blood cell distribution width with mortality in type A aortic dissection after surgery

    Bufan Zhang · Tianjin Medical University General Hospital, China

    Objective: Aortic dissection is closely associated with inflammation. Currently, red blood cell distribution width (RDW) has been regarded as a novel inflammatory biomarker. The role of RDW on the prognosis of patients…

  4. Keynote · In-Person

    A fatal case of group B strep endocarditis

    Bhavya Parikh · North Shore-Long Island Jewish, United States

    Streptococcus agalactiae, commonly known as Group B strep (GBS), is an uncommon pathogen in most adults and is typically only seen in pregnant women and neonates. Local and systemic complications from GBS typically have…

  5. Keynote · In-Person

    Assessing quality of content on TikTok: Postural orthostatic tachycardia syndrome

    Hannah Visser · William Carey University College of Osteopathic Medicine, United States

    Background: According to a study conducted in 2020 there is a prevalence of .2% of the general population living with Postural Orthostatic Tachycardia Syndrome. However, due to the covid-19 pandemic, rates of diagnosis…

  6. Keynote · In-Person

    Comparative outcomes of mitraclip therapy versus surgical and conservative management for mitral regurgitation: A meta-analysis

    Afrasayab Khan · Central Michigan University, United States

    Background: Mitral regurgitation (MR) is a prevalent valvular heart disease associated with significant morbidity and mortality. While surgical mitral valve repair or replacement remains the gold standard, transcatheter…

  7. Keynote · In-Person

    Meta-analysis of Fractional Flow Reserve (FFR) vs. Instantaneous Wave-Free Ratio (IFR) in coronary revascularization: A comparative evaluation of outcomes

    Afrasayab Khan · Central Michigan University, United States

    Background: Fractional Flow Reserve (FFR) is the gold standard for guiding percutaneous coronary intervention (PCI) by assessing the hemodynamic significance of coronary lesions. However, its use is limited by the need…

  8. Keynote · In-Person

    Effect of corticosterone on blood pressure in SHR ovariectomized rats

    Yanina Alejandra Santander Plantamura · National Autonomous University of Mexico, Mexico

    Introduction: Hypertension (HTA) is a major risk factor for cardiovascular diseases. Spontaneously hypertensive rats (SHR) serve as a genetic model that mimics the characteristics of human disease. Female SHR generally…

  9. Oral · Virtual

    Pulse field ablation for atrial fibrillation complications: What do we know yet

    Narendra Kumar · HeartbeatsZ Academy, United Kingdom

    Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide. While catheter ablation is a well-established treatment for AF, it carries risks of complications such as pulmonary vein…

  10. Oral · Virtual

    Comprehensive surgical revascularization for rapidly worsening ischemic heart failure

    Deepak Puri · Max Healthcare, India

    Ischemic Heart Failure usually occurs due to delayed treatment of coronary artery disease. Rapidly worsening ischemic heart failure can occur due to Acute onset STEMI in a patient with critical multi vessel coronary…

  11. Presentation

    Follow up of ischemic heart failure patients after surgical revascularization

    Vinakshi Devi · Max Super Specialty Hospital, India

    Ischemic heart failure (IHF), primarily resulting from Coronary Artery Disease, remains a significant cause of morbidity and mortality globally. Surgical revascularization, particularly off- pump coronary artery bypass…

  12. Presentation

    Role of vericiguat in acute decompensating heart failure

    Jasmine · Chandigarh Group of Colleges, India

    Vericiguat is a novel oral soluble guanylate cyclase (sGC) stimulator used in the treatment of heart failure with reduced ejection fraction (HFrEF). It belongs to a new class of medications that enhance the cyclic…

  13. Presentation

    Peripheral artery disease: Unveiling its impact on cardiovascular events and outcomes

    Somya Puri · Medical Officer Co-ordinator of Yung Forum, Cardiomersion, India

    Peripheral artery disease (PAD) is a prevalent but underrecognized atherosclerotic disease that carries a powerful prognostic weight. Lower extremity PAD affects an estimated 8.5 million Americans over age 40 and…

  14. Presentation

    Audit on the clinical use of procalcitonin: A comparison of practice between emergency department and acute medicine (McGill) doctors

    Nikita Goyal · NHS, United Kingdom

    Introduction: Bacterial infection leads to the activation of CALC—1 gene and production of PCT in all parenchymal tissues in response to bacterial infection. Most tissues, except the thyroid gland C-cells and some…

  15. Presentation

    Internal thoracic artery: Anatomical variations to be considered for bilateral harvesting

    Nidhi Puri · AIIMS Bilaspur, India

    The internal thoracic artery (ITA) is a preferred conduit in coronary artery bypass graft (CABG) surgery due to its predictable intrathoracic course, proximity to the heart, and excellent long-term patency. Bilateral…

  16. Presentation

    Heart-smart workplaces: Workplace-based interventions for cardiovascular risk reduction

    Surabhi Puri · AIIMS, India

    Background: Cardiovascular diseases (CVDs) remain the leading global cause of mortality, with a significant proportion attributable to modifiable behavioral and metabolic risk factors. In India, the rising burden of CVD…

  17. Presentation

    Management of post heart transplant complications

    Manoj Sahu · AIIMS, India

    Heart transplant rejection remains a significant challenge, threatening the long-term success of heart transplantation. Acute Cellular Rejection (ACR) is most common type and occurs within first year of transplant.…

  18. Presentation

    Minimally invasive cardiac surgery in congenital heart diseases: The new horizon

    Amitabh Satsangi · AIIMS, India

    Sternotomy has been the most common approach for the correction of congenital cardiac defects, and questions arise surrounding the safety, feasibility, and cost-effectiveness of implementing minimally invasive…

  19. Presentation

    How robotic technology will shape the future of minimally invasive cardiac surgery

    Johannes Bonatti · University of Pittsburgh, United States

    Robotic techniques have been used in cardiac surgery since the late 1990s. After an initial hype other surgical disciplines have taken up the technology with more enthusiasm and have given significant input for further…

  20. Presentation

    Benefits of modified uniportal VATS for management of complex thoracic cases

    Deepak Puri · Max Healthcare, India

    Uniportal Video Assisted Thoracoscopic Surgeries (UVATS) have advantage of making Thoracic Surgery minimally invasive without compromising on outcome. VATS was initially performed through multiple ports but in patients…

  21. Presentation

    Advances in minimally invasive cardiac surgery

    Eric J Lehr · Cherry Hill Campus, United States

    Minimally invasive cardiac surgery has entered a new era, propelled by advances in robotics and Artificial Intelligence (AI). This presentation explores how these technologies are reshaping surgical care across the full…

Day 3

Day 3

  1. Oral · Virtual

    Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors

    Mekhman N Mamedov · National Research Center for Preventive Medicine, Russian Federation

    Oncological diseases are the second most common cause of death among adults worldwide after cardiovascular diseases (CVD). In clinical practice, comorbidity of cancers and CVD is increasingly registered, which certainly…

  2. Oral · Virtual

    Lipoprotein (a): The hidden cardiovascular risk

    Syed Raza · Awali Hospital, Bahrain

    Lipoprotein (a) [Lp(a)] is a unique lipoprotein particle composed of an LDL-like particle linked to a glycoprotein called apolipoprotein(a). Elevated levels of Lp(a) have been identified as an independent risk factor…

  3. Oral · Virtual

    Surgical fetal stem cells implantation in heart failure patients long term results at 14 years

    Federico Benetti · Benetti Foundation, Argentina

    Direct myocardial transplantation of HFDSCs (Fetal Liver Stem Cells) by open-chest surgical procedure was performed in 10 patients with HF due to nonischemic, nonchagasic dilated cardiomyopathy. All 10 patients survived…

  4. Oral · Virtual

    Cardiovascular nanomedicine: Stopping strokes, unclogging arteries, and restoring heart function

    Thomas J Webster · Brown University, United States

    Nanomedicine, or the use of materials with at least one dimension less than 100 nm, has led to improved disease prevention, diagnosis, and treatment. This talk will cover recent advances in the use of nanomaterials to…

  5. Poster

    Free fatty acids: Independent predictors of long-term adverse cardiovascular outcomes in heart failure patients

    Guang Zhi Liao · Peking Union Medical College, China

    Background: The association between plasma free fatty acid (FFA) and the outcomes in the heart failure (HF) patients remains unclear. Methods: A cohort study among HF patients was performed. Plasma FFA was analyzed as…

  6. Poster

    Cardiovascular outcomes in initial and sustained orthostatic hypotension: A retrospective cohort study

    Hui Geng · Peking University First Hospital, China

    Classic orthostatic hypotension (OH) is a common geriatric disorder and is associated with cardiovascular risk. There are so far too few data available on the prognostic importance of initial OH and the comparison with…

  7. Poster

    Mutual concomitance of pancytopenia and chronic heart failure in patients infected with human immunodeficiency virus

    Olga G Goryacheva · Perm State Medical university, Russian Federation

    Human immunodeficiency virus (HIV) has direct and indirect effects on both bone marrow cells and cardiomyocytes. The common pathogenetic process unites the formation of pancytopenia and chronic heart failure (CHF) in…

  8. Poster

    Left ventricular rupture following mitral valve replacement

    Vikram Jitendra · Aberdeen Royal Infirmary, United Kingdom

    Left Ventricular (LV) Rupture after Mitral Valve Replacement is a serious complication and carries a very high mortality. Fortunately it is not common but nevertheless it can happen without any warning and catch the…

  9. Poster

    Comparison of autologous vs non-autologous blood transfusion in patients undergoing coronary artery bypass grafting surgery

    Muhammad Wasim Sajjad · Rehman Medical Institute, Pakistan

    Introduction: To compare autologous versus non-autologous transfusion in patients undergoing CABG and its early outcomes. This study seeks to evaluate the impact of different transfusion strategies on key postoperative…

  10. Poster

    Heart-to-Heart: Transforming cardiac care through communication

    Iris Panagiota Efthymiou · Regent College London, United Kingdom

    Effective communication is at the heart of quality patient care, especially in cardiology, where complex medical decisions can significantly impact patient outcomes. This speech addresses the critical role of…

  11. Poster

    Prescribing patterns and risk factor assessment in coronary artery disease patients undergoing angioplasty: A prospective study

    Nilay Solanki · Charotar University of Science and Technology, India

    Background: Coronary artery disease (CAD) results from the obstruction of blood supply to the heart. Angioplasty is a common intervention for managing CAD, supplemented by supportive and preventive therapies. Modifiable…

  12. Poster

    Nature’s pharmacy: Phytoconstituents for cardiovascular wellness

    Geeta Deswal · Guru Gobind Singh College of Pharmacy, India

    Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide. Modern pharmacology offers a variety of treatments, yet the rising prevalence of CVDs necessitates alternative and complementary…

  13. Poster

    Design of textile biodegradable composite stent having core shell structure

    Narayanan Gokarneshan · SSM College of Engineering, India

    Composite textile stents with core-shell structure have been developed. Biodegradable polyvinyl alcohol (PVA) yarns are twisted and then coated with polycaprolactone/polyethylene glycol (PEG) blends. The coated yarns…

  14. Poster

    Neuronal cholesterol homeostasis and lipid receptors

    Maria Borrell · Institut de Recerca Sant Pau - Centre CERCA, Spain

    Although the regulation of cholesterol homeostasis in the body has been extensively studied, there is little information on how this regulation takes place in the brain. Cholesterol does not cross the blood-brain…

  15. Poster

    7 stepwise approach in ECG interpretation using cardiac vector theory

    T Rajini Samuel · Shri Sathya Sai Medical College and Research Institute, India

    Introduction: Electrocardiogram (ECG) interpretation plays an immense clinical role for the diagnosis of coronary heart disease. But its interpretation remains a challenging task for junior medical staffs. Einthoven…

  16. Poster

    Sinusoidal atrial fibrillation (Yasser’s Fibrillation) and partial SAN function in COVID-19 pneumonia; A new cardiovascular discovery change in atrial fibrillation directory-case series

    Yasser Mohammed Hassanain Elsayed · Egyptian Ministry of Health, Egypt

    Introduction: Atrial fibrillation (AF) is one of the most common and probable serious arrhythmia and a hallmark of an increasing risk of pathological thrombus formation. Interestingly, normal sinus rhythm (NSR) is the…

  17. Poster

    Unraveling cardiovascular dynamics: Kinetic modeling using heart function as an input variable in physiological systems

    Tahmineh Azizi · Florida State University, United States

    Kinetic modeling is an essential method in understanding the dynamic interactions of biological systems, particularly in the context of cardiovascular physiology. This study delves into the application of kinetic…

  18. Poster

    Safety and outcomes of cardiopulmonary resuscitation in patients with left ventricular assist devices

    Ryan Slaughenhaupt · University of Cincinnati College of Medicine, United States

    Annually, approximately 2,500 – 3000 patients in the United States receive left ventricular assist devices (LVADs), making it increasingly likely that healthcare providers and EMS will encounter cardiac emergencies in…

  19. Poster

    Gender disparities in heart disease, diagnosis and management

    Asma Syed · Brookdale Hospital Medical Center, United States

    Heart disease is the leading cause of death worldwide effecting both men and women, however gender disparities are present in the diagnosis, treatment and even clinical outcomes. Clinical trials in cardiovascular…

  20. Poster

    Effects of impaired microcirculation in the musculoskeletal system

    Roger H Coletti · Interventional Health, United States

    Throughout the body blood flow is regulated by vascular tone secondary to local or neurologic control. However, in the musculoskeletal system, the effects of muscular contraction can lead to augmentation or restriction…

  21. Poster

    Predictors of sudden death in congenital arrhythmogenic syndromes

    Samir Rafla · Alexandria University, Egypt

    Genetic heart diseases are common causes of sudden cardiac death (SCD) in the young and are typically divided into inherited cardiomyopathies and primary electrical heart diseases. Cardiomyopathies associated with the…

  22. Poster

    Residual cardiovascular risk indices I and II in type II diabetics and hypertensive patients

    Agustin Joison · Cordoba Catholic University, Argentina

    Introduction: Diseases such as acute coronary syndromes (ACS), with signs such as difficulty breathing when exerting effort or chest pain at rest, are frequently expressed in patients with coronary artery diseases…

  23. Poster

    Factors that impact adherence to physical exercise in individuals with chronic pain

    Joao Rafael De Oliveira Rocha Da Silva · Connect Life Rehabilitation and Performance, Brazil

    Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis. In…

  24. Poster

    Optimizing the role of the electrophysiology advanced practice nurse in the hospital

    Esther M Weiss · Advocate Sherman Hospital, United States

    The APN functions as the patient advocate, the care facilitator and the optimizer of the patient’s hospital journey and experience. Areas of practice: Advanced knowledge and experience in the management of implanted…

  25. Poster

    Harnessing heart health: Unveiling the dual benefits of SGLT2 inhibitors in rat hearts

    Desislava Doycheva · Loma Linda University, United States

    Cardiovascular diseases, particularly myocardial infarction (MI), remain a major global health challenge. Recent studies have highlighted the cardioprotective potential of sodium-glucose co-transporter 2 (SGLT2)…

  26. Poster

    Baseline cardiac status in pregnant patients with sickle cell disease

    Roselyn Oyenug · University of Connecticut, United States

    Introduction: Sickle Cell Disease (SCD) is the most common inherited hemoglobinopathy, marked by chronic hemolytic anemia and vaso-occlusion due to a mutation in the β-globin gene. This leads to multi-organ damage and…

Present your research at Heart Congress 2027

Abstract submissions for the 2027 program are open · June 24–26, 2027 · NH Villa Carpegna, Rome.

Submit Abstract →

Join the Heart Congress 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us